Alvin Griffin, MD
Family Medicine · Conyers, GANPI 1033102868
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,995 of the $3,863 with a category attached, or 77.5%. 21 manufacturers reported payments, led by AstraZeneca at 33.5% of the total.
Across 148 payments — averaging $26.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$1K
- Abbott$314
- Daiichi Sankyo Inc.$263
- AbbVie$149
- Lilly USA, LLC$137
- plus $651 from 15 others
Across 16 payments — averaging $26,861 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$221K
- Eli Lilly$198K
- Alnylam Pharmaceuticals Inc.$11K
What the payments were for
- Travel & lodging$86822%
- Food & beverage$2,99578%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $1,295 |
| Novo Nordisk | 76 | $1,053 |
| Abbott | 4 | $314 |
| Daiichi Sankyo Inc. | 13 | $263 |
| AbbVie | 3 | $149 |
| Lilly USA, LLC | 8 | $137 |
| Eisai Inc. | 7 | $126 |
| GSK | 1 | $121 |
| Boehringer Ingelheim | 8 | $107 |
| Pfizer | 2 | $61 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Merck | 2 | $23 |
| Johnson & Johnson | 1 | $20 |
| Inogen, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Optinose US, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Gilead | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre$146
- Saxenda$125
- FreeStyle Libre Pro$124
- TRELEGY ELLIPTA$121
- Ozempic$114
How this compares
$3,863 in reported general payments places this provider in the 80th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Conyers
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
- Nadine Halliburton-FosterCumming$219K
- Contessa MetcalfeAtlanta$157K
- Elmore AlexanderStone Mountain$155K
- Bantwal BaligaColumbus$115K
- Avril CampbellFort Benning$108K
- Mitzi RubinMarietta$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.